Global Octreotide Drugs Supply, Demand and Key Producers, 2024-2030
Page: 119
Published Date: 11 Oct 2024
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
Octreotide drugs are synthetic analogues of somatostatin, designed to mimic the natural hormone's effects in the body. They are primarily used to treat conditions such as acromegaly, neuroendocrine tumors, and gastrointestinal disorders like carcinoid syndrome by inhibiting the secretion of various hormones.
The global Octreotide Drugs market size is expected to reach $ 3501 million by 2030, rising at a market growth of 3.3% CAGR during the forecast period (2024-2030).
The market for octreotide drugs is witnessing steady growth, driven by the increasing prevalence of hormone-related disorders, particularly acromegaly and neuroendocrine tumors. As awareness of these conditions grows and diagnostic techniques improve, more patients are being identified and treated, leading to higher demand for effective therapies like octreotide.
Recent advancements in formulation and delivery methods have also influenced the octreotide market. The development of long-acting formulations has improved patient compliance by reducing the frequency of injections, thus enhancing the overall treatment experience. Additionally, ongoing research into new therapeutic applications of octreotide, such as its potential use in managing other conditions like gastrointestinal bleeding and pain management, is expanding the market landscape. This diversification of applications is likely to attract interest from pharmaceutical companies and healthcare providers alike.
Furthermore, the global shift towards personalized medicine is shaping the market for octreotide drugs. As healthcare providers increasingly focus on tailored treatment approaches based on individual patient needs, octreotide's versatility as a targeted therapy positions it well in this evolving landscape. The integration of octreotide into broader treatment protocols, alongside other therapies and supportive care measures, is expected to drive its adoption further, positioning the octreotide market for sustained growth in the coming years.
This report studies the global Octreotide Drugs production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Octreotide Drugs and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Octreotide Drugs that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Octreotide Drugs total production and demand, 2019-2030, (K Units)
Global Octreotide Drugs total production value, 2019-2030, (USD Million)
Global Octreotide Drugs production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units), (based on production site)
Global Octreotide Drugs consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Octreotide Drugs domestic production, consumption, key domestic manufacturers and share
Global Octreotide Drugs production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Octreotide Drugs production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Octreotide Drugs production by Application, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
This report profiles key players in the global Octreotide Drugs market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, Sun Pharmaceutical, Teva, Gland Pharma, Chiesi Farmaceutici S.p.A, Fresenius Kabi, Mylan, Sagent Pharmaceuticals, West-Ward Pharmaceuticals, Suzhou Tianma Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Octreotide Drugs market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global Octreotide Drugs Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Octreotide Drugs Market, Segmentation by Type:
Injections
Oral Capsules
Global Octreotide Drugs Market, Segmentation by Application:
Neuroendocrine Tumors
Acromegaly
Other
Companies Profiled:
Novartis
Sun Pharmaceutical
Teva
Gland Pharma
Chiesi Farmaceutici S.p.A
Fresenius Kabi
Mylan
Sagent Pharmaceuticals
West-Ward Pharmaceuticals
Suzhou Tianma Pharmaceutical
Sihuan Pharmaceutical
Chengdu Tiantaishan pharmaceutical
Hybio Pharmaceutical
Key Questions Answered:
1. How big is the global Octreotide Drugs market?
2. What is the demand of the global Octreotide Drugs market?
3. What is the year over year growth of the global Octreotide Drugs market?
4. What is the production and production value of the global Octreotide Drugs market?
5. Who are the key producers in the global Octreotide Drugs market?
6. What are the growth factors driving the market demand?
Table of Contents
1 Supply Summary
1.1 Octreotide Drugs Introduction
1.2 World Octreotide Drugs Supply & Forecast
1.2.1 World Octreotide Drugs Production Value (2019 & 2023 & 2030)
1.2.2 World Octreotide Drugs Production (2019-2030)
1.2.3 World Octreotide Drugs Pricing Trends (2019-2030)
1.3 World Octreotide Drugs Production by Region (Based on Production Site)
1.3.1 World Octreotide Drugs Production Value by Region (2019-2030)
1.3.2 World Octreotide Drugs Production by Region (2019-2030)
1.3.3 World Octreotide Drugs Average Price by Region (2019-2030)
1.3.4 North America Octreotide Drugs Production (2019-2030)
1.3.5 Europe Octreotide Drugs Production (2019-2030)
1.3.6 China Octreotide Drugs Production (2019-2030)
1.3.7 Japan Octreotide Drugs Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Octreotide Drugs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Octreotide Drugs Major Market Trends
2.1 World Octreotide Drugs Demand (2019-2030)
2.2 World Octreotide Drugs Consumption by Region
2.2.1 World Octreotide Drugs Consumption by Region (2019-2024)
2.2.2 World Octreotide Drugs Consumption Forecast by Region (2025-2030)
2.3 United States Octreotide Drugs Consumption (2019-2030)
2.4 China Octreotide Drugs Consumption (2019-2030)
2.5 Europe Octreotide Drugs Consumption (2019-2030)
2.6 Japan Octreotide Drugs Consumption (2019-2030)
2.7 South Korea Octreotide Drugs Consumption (2019-2030)
2.8 ASEAN Octreotide Drugs Consumption (2019-2030)
2.9 India Octreotide Drugs Consumption (2019-2030)
3.1 World Octreotide Drugs Production Value by Manufacturer (2019-2024)
3.2 World Octreotide Drugs Production by Manufacturer (2019-2024)
3.3 World Octreotide Drugs Average Price by Manufacturer (2019-2024)
3.4 Octreotide Drugs Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Octreotide Drugs Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Octreotide Drugs in 2023
3.5.3 Global Concentration Ratios (CR8) for Octreotide Drugs in 2023
3.6 Octreotide Drugs Market: Overall Company Footprint Analysis
3.6.1 Octreotide Drugs Market: Region Footprint
3.6.2 Octreotide Drugs Market: Company Product Type Footprint
3.6.3 Octreotide Drugs Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4.1 United States VS China: Octreotide Drugs Production Value Comparison
4.1.1 United States VS China: Octreotide Drugs Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: Octreotide Drugs Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Octreotide Drugs Production Comparison
4.2.1 United States VS China: Octreotide Drugs Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Octreotide Drugs Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Octreotide Drugs Consumption Comparison
4.3.1 United States VS China: Octreotide Drugs Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: Octreotide Drugs Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Octreotide Drugs Manufacturers and Market Share, 2019-2024
4.4.1 United States Based Octreotide Drugs Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Octreotide Drugs Production Value (2019-2024)
4.4.3 United States Based Manufacturers Octreotide Drugs Production (2019-2024)
4.5 China Based Octreotide Drugs Manufacturers and Market Share
4.5.1 China Based Octreotide Drugs Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Octreotide Drugs Production Value (2019-2024)
4.5.3 China Based Manufacturers Octreotide Drugs Production (2019-2024)
4.6 Rest of World Based Octreotide Drugs Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based Octreotide Drugs Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Octreotide Drugs Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers Octreotide Drugs Production (2019-2024)
5.1 World Octreotide Drugs Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Injections
5.2.2 Oral Capsules
5.3 Market Segment by Type
5.3.1 World Octreotide Drugs Production by Type (2019-2030)
5.3.2 World Octreotide Drugs Production Value by Type (2019-2030)
5.3.3 World Octreotide Drugs Average Price by Type (2019-2030)
6.1 World Octreotide Drugs Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Neuroendocrine Tumors
6.2.2 Acromegaly
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Octreotide Drugs Production by Application (2019-2030)
6.3.2 World Octreotide Drugs Production Value by Application (2019-2030)
6.3.3 World Octreotide Drugs Average Price by Application (2019-2030)
7.1 Novartis
7.1.1 Novartis Details
7.1.2 Novartis Major Business
7.1.3 Novartis Octreotide Drugs Product and Services
7.1.4 Novartis Octreotide Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 Novartis Recent Developments/Updates
7.1.6 Novartis Competitive Strengths & Weaknesses
7.2 Sun Pharmaceutical
7.2.1 Sun Pharmaceutical Details
7.2.2 Sun Pharmaceutical Major Business
7.2.3 Sun Pharmaceutical Octreotide Drugs Product and Services
7.2.4 Sun Pharmaceutical Octreotide Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 Sun Pharmaceutical Recent Developments/Updates
7.2.6 Sun Pharmaceutical Competitive Strengths & Weaknesses
7.3 Teva
7.3.1 Teva Details
7.3.2 Teva Major Business
7.3.3 Teva Octreotide Drugs Product and Services
7.3.4 Teva Octreotide Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 Teva Recent Developments/Updates
7.3.6 Teva Competitive Strengths & Weaknesses
7.4 Gland Pharma
7.4.1 Gland Pharma Details
7.4.2 Gland Pharma Major Business
7.4.3 Gland Pharma Octreotide Drugs Product and Services
7.4.4 Gland Pharma Octreotide Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 Gland Pharma Recent Developments/Updates
7.4.6 Gland Pharma Competitive Strengths & Weaknesses
7.5 Chiesi Farmaceutici S.p.A
7.5.1 Chiesi Farmaceutici S.p.A Details
7.5.2 Chiesi Farmaceutici S.p.A Major Business
7.5.3 Chiesi Farmaceutici S.p.A Octreotide Drugs Product and Services
7.5.4 Chiesi Farmaceutici S.p.A Octreotide Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 Chiesi Farmaceutici S.p.A Recent Developments/Updates
7.5.6 Chiesi Farmaceutici S.p.A Competitive Strengths & Weaknesses
7.6 Fresenius Kabi
7.6.1 Fresenius Kabi Details
7.6.2 Fresenius Kabi Major Business
7.6.3 Fresenius Kabi Octreotide Drugs Product and Services
7.6.4 Fresenius Kabi Octreotide Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.6.5 Fresenius Kabi Recent Developments/Updates
7.6.6 Fresenius Kabi Competitive Strengths & Weaknesses
7.7 Mylan
7.7.1 Mylan Details
7.7.2 Mylan Major Business
7.7.3 Mylan Octreotide Drugs Product and Services
7.7.4 Mylan Octreotide Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.7.5 Mylan Recent Developments/Updates
7.7.6 Mylan Competitive Strengths & Weaknesses
7.8 Sagent Pharmaceuticals
7.8.1 Sagent Pharmaceuticals Details
7.8.2 Sagent Pharmaceuticals Major Business
7.8.3 Sagent Pharmaceuticals Octreotide Drugs Product and Services
7.8.4 Sagent Pharmaceuticals Octreotide Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.8.5 Sagent Pharmaceuticals Recent Developments/Updates
7.8.6 Sagent Pharmaceuticals Competitive Strengths & Weaknesses
7.9 West-Ward Pharmaceuticals
7.9.1 West-Ward Pharmaceuticals Details
7.9.2 West-Ward Pharmaceuticals Major Business
7.9.3 West-Ward Pharmaceuticals Octreotide Drugs Product and Services
7.9.4 West-Ward Pharmaceuticals Octreotide Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.9.5 West-Ward Pharmaceuticals Recent Developments/Updates
7.9.6 West-Ward Pharmaceuticals Competitive Strengths & Weaknesses
7.10 Suzhou Tianma Pharmaceutical
7.10.1 Suzhou Tianma Pharmaceutical Details
7.10.2 Suzhou Tianma Pharmaceutical Major Business
7.10.3 Suzhou Tianma Pharmaceutical Octreotide Drugs Product and Services
7.10.4 Suzhou Tianma Pharmaceutical Octreotide Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.10.5 Suzhou Tianma Pharmaceutical Recent Developments/Updates
7.10.6 Suzhou Tianma Pharmaceutical Competitive Strengths & Weaknesses
7.11 Sihuan Pharmaceutical
7.11.1 Sihuan Pharmaceutical Details
7.11.2 Sihuan Pharmaceutical Major Business
7.11.3 Sihuan Pharmaceutical Octreotide Drugs Product and Services
7.11.4 Sihuan Pharmaceutical Octreotide Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.11.5 Sihuan Pharmaceutical Recent Developments/Updates
7.11.6 Sihuan Pharmaceutical Competitive Strengths & Weaknesses
7.12 Chengdu Tiantaishan pharmaceutical
7.12.1 Chengdu Tiantaishan pharmaceutical Details
7.12.2 Chengdu Tiantaishan pharmaceutical Major Business
7.12.3 Chengdu Tiantaishan pharmaceutical Octreotide Drugs Product and Services
7.12.4 Chengdu Tiantaishan pharmaceutical Octreotide Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.12.5 Chengdu Tiantaishan pharmaceutical Recent Developments/Updates
7.12.6 Chengdu Tiantaishan pharmaceutical Competitive Strengths & Weaknesses
7.13 Hybio Pharmaceutical
7.13.1 Hybio Pharmaceutical Details
7.13.2 Hybio Pharmaceutical Major Business
7.13.3 Hybio Pharmaceutical Octreotide Drugs Product and Services
7.13.4 Hybio Pharmaceutical Octreotide Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.13.5 Hybio Pharmaceutical Recent Developments/Updates
7.13.6 Hybio Pharmaceutical Competitive Strengths & Weaknesses
8.1 Octreotide Drugs Industry Chain
8.2 Octreotide Drugs Upstream Analysis
8.2.1 Octreotide Drugs Core Raw Materials
8.2.2 Main Manufacturers of Octreotide Drugs Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Octreotide Drugs Production Mode
8.6 Octreotide Drugs Procurement Model
8.7 Octreotide Drugs Industry Sales Model and Sales Channels
8.7.1 Octreotide Drugs Sales Model
8.7.2 Octreotide Drugs Typical Distributors
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
Table of Figures
List of Tables
Table 1. World Octreotide Drugs Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World Octreotide Drugs Production Value by Region (2019-2024) & (USD Million)
Table 3. World Octreotide Drugs Production Value by Region (2025-2030) & (USD Million)
Table 4. World Octreotide Drugs Production Value Market Share by Region (2019-2024)
Table 5. World Octreotide Drugs Production Value Market Share by Region (2025-2030)
Table 6. World Octreotide Drugs Production by Region (2019-2024) & (K Units)
Table 7. World Octreotide Drugs Production by Region (2025-2030) & (K Units)
Table 8. World Octreotide Drugs Production Market Share by Region (2019-2024)
Table 9. World Octreotide Drugs Production Market Share by Region (2025-2030)
Table 10. World Octreotide Drugs Average Price by Region (2019-2024) & (US$/Unit)
Table 11. World Octreotide Drugs Average Price by Region (2025-2030) & (US$/Unit)
Table 12. Octreotide Drugs Major Market Trends
Table 13. World Octreotide Drugs Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
Table 14. World Octreotide Drugs Consumption by Region (2019-2024) & (K Units)
Table 15. World Octreotide Drugs Consumption Forecast by Region (2025-2030) & (K Units)
Table 16. World Octreotide Drugs Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key Octreotide Drugs Producers in 2023
Table 18. World Octreotide Drugs Production by Manufacturer (2019-2024) & (K Units)
Table 19. Production Market Share of Key Octreotide Drugs Producers in 2023
Table 20. World Octreotide Drugs Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 21. Global Octreotide Drugs Company Evaluation Quadrant
Table 22. World Octreotide Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and Octreotide Drugs Production Site of Key Manufacturer
Table 24. Octreotide Drugs Market: Company Product Type Footprint
Table 25. Octreotide Drugs Market: Company Product Application Footprint
Table 26. Octreotide Drugs Competitive Factors
Table 27. Octreotide Drugs New Entrant and Capacity Expansion Plans
Table 28. Octreotide Drugs Mergers & Acquisitions Activity
Table 29. United States VS China Octreotide Drugs Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China Octreotide Drugs Production Comparison, (2019 & 2023 & 2030) & (K Units)
Table 31. United States VS China Octreotide Drugs Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
Table 32. United States Based Octreotide Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Octreotide Drugs Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers Octreotide Drugs Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers Octreotide Drugs Production (2019-2024) & (K Units)
Table 36. United States Based Manufacturers Octreotide Drugs Production Market Share (2019-2024)
Table 37. China Based Octreotide Drugs Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Octreotide Drugs Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers Octreotide Drugs Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers Octreotide Drugs Production, (2019-2024) & (K Units)
Table 41. China Based Manufacturers Octreotide Drugs Production Market Share (2019-2024)
Table 42. Rest of World Based Octreotide Drugs Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Octreotide Drugs Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers Octreotide Drugs Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers Octreotide Drugs Production, (2019-2024) & (K Units)
Table 46. Rest of World Based Manufacturers Octreotide Drugs Production Market Share (2019-2024)
Table 47. World Octreotide Drugs Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World Octreotide Drugs Production by Type (2019-2024) & (K Units)
Table 49. World Octreotide Drugs Production by Type (2025-2030) & (K Units)
Table 50. World Octreotide Drugs Production Value by Type (2019-2024) & (USD Million)
Table 51. World Octreotide Drugs Production Value by Type (2025-2030) & (USD Million)
Table 52. World Octreotide Drugs Average Price by Type (2019-2024) & (US$/Unit)
Table 53. World Octreotide Drugs Average Price by Type (2025-2030) & (US$/Unit)
Table 54. World Octreotide Drugs Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World Octreotide Drugs Production by Application (2019-2024) & (K Units)
Table 56. World Octreotide Drugs Production by Application (2025-2030) & (K Units)
Table 57. World Octreotide Drugs Production Value by Application (2019-2024) & (USD Million)
Table 58. World Octreotide Drugs Production Value by Application (2025-2030) & (USD Million)
Table 59. World Octreotide Drugs Average Price by Application (2019-2024) & (US$/Unit)
Table 60. World Octreotide Drugs Average Price by Application (2025-2030) & (US$/Unit)
Table 61. Novartis Basic Information, Manufacturing Base and Competitors
Table 62. Novartis Major Business
Table 63. Novartis Octreotide Drugs Product and Services
Table 64. Novartis Octreotide Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. Novartis Recent Developments/Updates
Table 66. Novartis Competitive Strengths & Weaknesses
Table 67. Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 68. Sun Pharmaceutical Major Business
Table 69. Sun Pharmaceutical Octreotide Drugs Product and Services
Table 70. Sun Pharmaceutical Octreotide Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. Sun Pharmaceutical Recent Developments/Updates
Table 72. Sun Pharmaceutical Competitive Strengths & Weaknesses
Table 73. Teva Basic Information, Manufacturing Base and Competitors
Table 74. Teva Major Business
Table 75. Teva Octreotide Drugs Product and Services
Table 76. Teva Octreotide Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Teva Recent Developments/Updates
Table 78. Teva Competitive Strengths & Weaknesses
Table 79. Gland Pharma Basic Information, Manufacturing Base and Competitors
Table 80. Gland Pharma Major Business
Table 81. Gland Pharma Octreotide Drugs Product and Services
Table 82. Gland Pharma Octreotide Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. Gland Pharma Recent Developments/Updates
Table 84. Gland Pharma Competitive Strengths & Weaknesses
Table 85. Chiesi Farmaceutici S.p.A Basic Information, Manufacturing Base and Competitors
Table 86. Chiesi Farmaceutici S.p.A Major Business
Table 87. Chiesi Farmaceutici S.p.A Octreotide Drugs Product and Services
Table 88. Chiesi Farmaceutici S.p.A Octreotide Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Chiesi Farmaceutici S.p.A Recent Developments/Updates
Table 90. Chiesi Farmaceutici S.p.A Competitive Strengths & Weaknesses
Table 91. Fresenius Kabi Basic Information, Manufacturing Base and Competitors
Table 92. Fresenius Kabi Major Business
Table 93. Fresenius Kabi Octreotide Drugs Product and Services
Table 94. Fresenius Kabi Octreotide Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 95. Fresenius Kabi Recent Developments/Updates
Table 96. Fresenius Kabi Competitive Strengths & Weaknesses
Table 97. Mylan Basic Information, Manufacturing Base and Competitors
Table 98. Mylan Major Business
Table 99. Mylan Octreotide Drugs Product and Services
Table 100. Mylan Octreotide Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 101. Mylan Recent Developments/Updates
Table 102. Mylan Competitive Strengths & Weaknesses
Table 103. Sagent Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 104. Sagent Pharmaceuticals Major Business
Table 105. Sagent Pharmaceuticals Octreotide Drugs Product and Services
Table 106. Sagent Pharmaceuticals Octreotide Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 107. Sagent Pharmaceuticals Recent Developments/Updates
Table 108. Sagent Pharmaceuticals Competitive Strengths & Weaknesses
Table 109. West-Ward Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 110. West-Ward Pharmaceuticals Major Business
Table 111. West-Ward Pharmaceuticals Octreotide Drugs Product and Services
Table 112. West-Ward Pharmaceuticals Octreotide Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 113. West-Ward Pharmaceuticals Recent Developments/Updates
Table 114. West-Ward Pharmaceuticals Competitive Strengths & Weaknesses
Table 115. Suzhou Tianma Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 116. Suzhou Tianma Pharmaceutical Major Business
Table 117. Suzhou Tianma Pharmaceutical Octreotide Drugs Product and Services
Table 118. Suzhou Tianma Pharmaceutical Octreotide Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 119. Suzhou Tianma Pharmaceutical Recent Developments/Updates
Table 120. Suzhou Tianma Pharmaceutical Competitive Strengths & Weaknesses
Table 121. Sihuan Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 122. Sihuan Pharmaceutical Major Business
Table 123. Sihuan Pharmaceutical Octreotide Drugs Product and Services
Table 124. Sihuan Pharmaceutical Octreotide Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 125. Sihuan Pharmaceutical Recent Developments/Updates
Table 126. Sihuan Pharmaceutical Competitive Strengths & Weaknesses
Table 127. Chengdu Tiantaishan pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 128. Chengdu Tiantaishan pharmaceutical Major Business
Table 129. Chengdu Tiantaishan pharmaceutical Octreotide Drugs Product and Services
Table 130. Chengdu Tiantaishan pharmaceutical Octreotide Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 131. Chengdu Tiantaishan pharmaceutical Recent Developments/Updates
Table 132. Chengdu Tiantaishan pharmaceutical Competitive Strengths & Weaknesses
Table 133. Hybio Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 134. Hybio Pharmaceutical Major Business
Table 135. Hybio Pharmaceutical Octreotide Drugs Product and Services
Table 136. Hybio Pharmaceutical Octreotide Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 137. Hybio Pharmaceutical Recent Developments/Updates
Table 138. Hybio Pharmaceutical Competitive Strengths & Weaknesses
Table 139. Global Key Players of Octreotide Drugs Upstream (Raw Materials)
Table 140. Global Octreotide Drugs Typical Customers
Table 141. Octreotide Drugs Typical Distributors
List of Figures
Figure 1. Octreotide Drugs Picture
Figure 2. World Octreotide Drugs Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Octreotide Drugs Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World Octreotide Drugs Production (2019-2030) & (K Units)
Figure 5. World Octreotide Drugs Average Price (2019-2030) & (US$/Unit)
Figure 6. World Octreotide Drugs Production Value Market Share by Region (2019-2030)
Figure 7. World Octreotide Drugs Production Market Share by Region (2019-2030)
Figure 8. North America Octreotide Drugs Production (2019-2030) & (K Units)
Figure 9. Europe Octreotide Drugs Production (2019-2030) & (K Units)
Figure 10. China Octreotide Drugs Production (2019-2030) & (K Units)
Figure 11. Japan Octreotide Drugs Production (2019-2030) & (K Units)
Figure 12. Octreotide Drugs Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Octreotide Drugs Consumption (2019-2030) & (K Units)
Figure 15. World Octreotide Drugs Consumption Market Share by Region (2019-2030)
Figure 16. United States Octreotide Drugs Consumption (2019-2030) & (K Units)
Figure 17. China Octreotide Drugs Consumption (2019-2030) & (K Units)
Figure 18. Europe Octreotide Drugs Consumption (2019-2030) & (K Units)
Figure 19. Japan Octreotide Drugs Consumption (2019-2030) & (K Units)
Figure 20. South Korea Octreotide Drugs Consumption (2019-2030) & (K Units)
Figure 21. ASEAN Octreotide Drugs Consumption (2019-2030) & (K Units)
Figure 22. India Octreotide Drugs Consumption (2019-2030) & (K Units)
Figure 23. Producer Shipments of Octreotide Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 24. Global Four-firm Concentration Ratios (CR4) for Octreotide Drugs Markets in 2023
Figure 25. Global Four-firm Concentration Ratios (CR8) for Octreotide Drugs Markets in 2023
Figure 26. United States VS China: Octreotide Drugs Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 27. United States VS China: Octreotide Drugs Production Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Octreotide Drugs Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 29. United States Based Manufacturers Octreotide Drugs Production Market Share 2023
Figure 30. China Based Manufacturers Octreotide Drugs Production Market Share 2023
Figure 31. Rest of World Based Manufacturers Octreotide Drugs Production Market Share 2023
Figure 32. World Octreotide Drugs Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 33. World Octreotide Drugs Production Value Market Share by Type in 2023
Figure 34. Injections
Figure 35. Oral Capsules
Figure 36. World Octreotide Drugs Production Market Share by Type (2019-2030)
Figure 37. World Octreotide Drugs Production Value Market Share by Type (2019-2030)
Figure 38. World Octreotide Drugs Average Price by Type (2019-2030) & (US$/Unit)
Figure 39. World Octreotide Drugs Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 40. World Octreotide Drugs Production Value Market Share by Application in 2023
Figure 41. Neuroendocrine Tumors
Figure 42. Acromegaly
Figure 43. Other
Figure 44. World Octreotide Drugs Production Market Share by Application (2019-2030)
Figure 45. World Octreotide Drugs Production Value Market Share by Application (2019-2030)
Figure 46. World Octreotide Drugs Average Price by Application (2019-2030) & (US$/Unit)
Figure 47. Octreotide Drugs Industry Chain
Figure 48. Octreotide Drugs Procurement Model
Figure 49. Octreotide Drugs Sales Model
Figure 50. Octreotide Drugs Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Novartis Sun Pharmaceutical Teva Gland Pharma Chiesi Farmaceutici S.p.A Fresenius Kabi Mylan Sagent Pharmaceuticals West-Ward Pharmaceuticals Suzhou Tianma Pharmaceutical Sihuan Pharmaceutical Chengdu Tiantaishan pharmaceutical Hybio Pharmaceutical
11 Oct 2024
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
